Exchange: NASDAQ·Updated 07:54 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 13

Estimated EPS

-$0.18

Reported EPS

-$0.18

Surprise

---

Estimated Rev

$27.01M

Reported Rev

$27.21M

Surprise

+0.75%

• Reported GAAP EPS of -$0.22 down -46.67% YoY • Mdxhealth maintains its 2026 revenue guidance of $110-115 million, representing 20-26% growth over 2025 excluding Resolve, and expects a return to positive adjusted EBITDA as Mdxhealth exits the year 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

6-K

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.09
--
--
N/A
Q2 '26
-$0.18
-$0.18
--
EXPECTED
Q1 '26
-$0.14
-$0.19
-31.35%
MISSED
Q4 '25
-$0.13
-$0.17
-35.48%
MISSED
Q3 '25
-$0.11
-$0.16
-49.73%
MISSED

Advertisement|Remove ads.